Abstract:Adenosine deaminase acting on RNA-1 (ADAR1) is a ubiquitously expressed RNA deaminase catalyzing adenosine-to-inosine editing to prevent hyperactivated cytosolic double-stranded RNA (dsRNA) response mediated by MDA5. Here, we demonstrate that ADAR1 is essential for early B lymphopoiesis from late pro-B and large pre-B cell stages onward. ADAR1 exerts its requisite role via both MDA5-dependent and -independent pathways. Interestingly, the MDA5-dependent mechanisms regulate early pro-B to large pre-B cell transition by promoting early B cell survival. In contrast, the MDA5-independent mechanisms control large pre-B to small pre-B cell transition by regulating pre-B cell receptor (pre-BCR) expression. Moreover, we show that protein kinase R (PKR) and oligoadenylate synthetase/ribonuclease (OAS/RNase) L pathways are dispensable for ADAR1's role in early B lymphopoiesis. Importantly, we demonstrate that p150 isoform of ADAR1 exclusively accounts for ADAR1's function in early B lymphopoiesis, and its conventional dsRNA-binding, but not the Z-DNA/RNA-binding or the RNA-editing, activity is required for ADAR1's function in B cell development. Thus, our findings suggest that ADAR1 regulates early B lymphopoiesis through various mechanisms. Introduction Hydrolytic deamination of adenosine (A) to inosine (I) within double-stranded RNAs (dsRNAs) is the most common form of post-transcriptional RNA modification. 1 Yu Z. Chen T. Cao X. RNA editing by ADAR1 marks dsRNA as "self". Cell Res. 2015; 25 : 1283-1284 https://doi.org/10.1038/cr.2015.135 Crossref PubMed Scopus (9) Google Scholar The A-to-I conversion can affect many biological processes, including recoding RNA, creating or destroying RNA splicing sites, changing RNA structure, and weakening dsRNA pairing. 2 Deng P. Khan A. Jacobson D. Sambrani N. McGurk L. Li X. Jayasree A. Hejatko J. Shohat-Ophir G. O'Connell M.A. et al. Adar RNA editing-dependent and -independent effects are required for brain and innate immune functions in Drosophila. Nat. Commun. 2020; 11 : 1580 https://doi.org/10.1038/s41467-020-15435-1 Crossref PubMed Scopus (20) Google Scholar The A-to-I editing is catalyzed by adenosine deaminase acting on RNA (ADAR) enzymes. 3 Roth S.H. Levanon E.Y. Eisenberg E. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity. Nat. Methods. 2019; 16 : 1131-1138 https://doi.org/10.1038/s41592-019-0610-9 Crossref PubMed Scopus (47) Google Scholar There are three ADAR isoforms in mammals: ADAR1, ADAR2, and ADAR3, all possessing highly conserved dsRNA-binding domains (dsRBDs) at their N terminus and a deaminase domain at the C terminus. 4 Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 2010; 79 : 321-349 https://doi.org/10.1146/annurev-biochem-060208-105251 Crossref PubMed Scopus (814) Google Scholar In addition, ADAR1 also carries Z-DNA-binding domains (Z-α and Z-β) in its N-terminal region. 5 Nichols P.J. Bevers S. <li class= -Abstract Truncated-

Emerging Role of the RNA-editing Enzyme ADAR1 in Stem Cell Fate and Function

Adenosine Deaminase Acting on RNA 1 (ADAR1) As Crucial Regulators in Cardiovascular Diseases: Structures, Pathogenesis, and Potential Therapeutic Approach

Origins And Evolution Of Adar-Mediated Rna Editing

ADAR1-Mediated RNA Editing and Its Role in Cancer

Origins and Evolution of ADAR‐mediated RNA Editing

The role of ADAR1 through and beyond its editing activity in cancer

RNA Editing, ADAR1, and the Innate Immune Response

ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner

The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses

Site-directed RNA editing by harnessing ADARs: advances and challenges

ADAR-mediated RNA Editing in Non-Coding RNA Sequences

The role of RNA editing enzyme ADAR1 in human disease

The Regulatory Function of ADAR1-mediated RNA Editing in Hematological Malignancies

ADAR1 is Essential for Intestinal Homeostasis and Stem Cell Maintenance

Mechanisms and Implications of ADAR-mediated RNA Editing in Cancer

Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity

Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications

The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways

Adenosine deaminase acting on RNA-1 is essential for early B lymphopoiesis

ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response

An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer